Fetal endocrine programming in the context of maternal thyroid and glucose dysregulation: the roles of placental transporters, hormonal interactions, and epigenetic mechanisms—an integrative systematic review

Read full text Summarise with VIRAT
Authors: Wiku Andonotopo, Muhammad Adrianes Bachnas, Wisnu Prabowo, Eric Edwin Yuliantara, Mochammad Besari Adi Pramono, Julian Dewantiningrum, Efendi Lukas, I Nyoman Hariyasa Sanjaya, Anak Agung Gede Putra Wiradnyana, Anak Agung Ngurah Jaya Kusuma, Ryan Saktika Mulyana, Khanisyah Erza Gumilar
+14 more Ernawati Darmawan, Muhammad Ilham Aldika Akbar, Dovy Djanas, Dudy Aldiansyah, Aloysius Suryawan, Ridwan Abdullah Putra, Anita Deborah Anwar, Cut Meurah Yeni, Nuswil Bernolian, Harry Kurniawan Gondo, Laksmana Adi Krista Nugraha, Waskita Ekamaheswara Kasumba Andanaputra, Wibisana Andika Krista Dharma, Milan Stanojevic
Cited by: 0
References: 40

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Maternal thyroid dysfunction and gestational disturbances in glucose regulation are each well-established determinants of altered fetal development. However, their combined effects and shared placental pathways have seldom been explored within an integrated framework. To address this gap, we conducted a Preferred Reporting Items for Systematic Reviews and Meta-Analyses-guided, structured literature synthesis examining how perturbations along the maternal thyroid–glucose axis during pregnancy may intersect at the placental level to influence fetal endocrine programming. Systematic searches of PubMed, Scopus, and Embase yielded 1329 records; of these, 40 studies fulfilled predefined inclusion criteria for qualitative synthesis, encompassing human observational studies, placental mechanistic research, epigenetic investigations, and integrative reviews. Rather than performing a quantitative meta-analysis, findings were evaluated thematically across biological domains to identify mechanistic convergence. Across heterogeneous study designs, recurring associations were observed between maternal thyroid and glycemic dysregulation and alterations in placental thyroid hormone transporters, including MCT8 and members of the organic anion transporting polypeptide family, as well as adaptive changes in deiodinase activity (DIO2 and DIO3). These disturbances frequently coincided with modifications in placental glucose transport, nutrient-sensing pathways, and metabolic signaling. Moreover, many studies reported accompanying epigenetic alterations, most notably changes in DNA methylation and microRNA expression, in key genes regulating energy metabolism, stress responses, and endocrine function, such as peroxisome proliferator–activated receptor gamma coactivator 1-alpha, leptin gene, insulin-like growth factor 2, and 11β-hydroxysteroid dehydrogenase type 2. Collectively, the evidence supports a conceptual model in which the placenta functions as an active endocrine and epigenetic mediator, translating maternal metabolic and hormonal signals into fetal adaptations that affect the thyroid axis, pancreatic development, and hypothalamic–pituitary–adrenal function. Although much of the existing literature is associative and mechanistic, the consistency of findings across independent lines of inquiry enhances biological plausibility and underscores critical knowledge gaps. Integrated evaluation of thyroid and metabolic function during pregnancy, together with placental and epigenetic research, may be essential for advancing understanding of fetal endocrine programming and its long-term health consequences.

Fields of Study & Subjects

Birth Development and Health Thyroid Disorders and Treatments Gestational Diabetes Research and Management

Publication details

Journal / source
MGM Journal of Medical Sciences
Volume
13
Issue
1
Pages
127–142
Publication date
1 January 2026
Language
EN